0001612630 true 0001612630 2022-02-24 2022-02-24 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K/A

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

 

Date of report (date of earliest event reported): February 24, 2022

 

 

The Joint Corp.

(Exact name of registrant as specified in its charter)

 

 

Delaware  001-36724  90-0544160
(State or other jurisdiction of incorporation)  (Commission file number)  (IRS employer identification number)

 

 

16767 N. Perimeter Drive, Suite 110

Scottsdale, AZ 85260

(Address of principal executive offices)

 

(480) 245-5960

Registrant’s telephone number, including area code

 

Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, $0.001 Par Value Per Share JYNT The NASDAQ Capital Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2). Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

EXPLANATORY NOTE

 

On February 24, 2022, The Joint Corp. (the “Company”) issued a press release (the “Original Press Release”) announcing its preliminary financial results for the fourth quarter and full year ended December 31, 2021 and filed a Current Report on Form 8-K furnishing the press release as Exhibit 99.1. On February 24, 2022, the Company issued an updated press release to correct the 2022 guidance appearing in the Original Press Release with respect to franchised clinic openings, which is expected to be between 110 to 130 (which was incorrectly published due to a clerical error in the Original Press Release as being between 130 to 140), compared to 110 in 2020. The Company is filing this amended Form 8-K to furnish the updated press release. Except as described above, all other information in the Original Press Release remains unchanged.

 

Item 2.02Results of Operations and Financial Condition

 

On February 24, 2022, the Company issued an updated press release announcing its preliminary financial results for the fourth quarter and full year ended December 31, 2021. A copy of the updated press release is furnished as Exhibit 99.1 to this amended Current Report on Form 8-K.

 

The information furnished in this Item 2.02 and Exhibit 99.1 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

 

Item 9.01Financial Statements and Exhibits.

 

(d)       Exhibits

Exhibit

Number

  Description
     
99.1   Updated Press Release dated February 24, 2022
104   Cover page interactive data file (embedded within the Inline XBRL document)

 

 

 

Signature

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: February 25, 2022

 

  The Joint Corp.
     
  By /s/ Peter D. Holt
    Peter D. Holt
    President and Chief Executive Officer

 

 

 

 

 

 

 

 

Joint (NASDAQ:JYNT)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Joint Charts.
Joint (NASDAQ:JYNT)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Joint Charts.